BRITTANY FLYNN: Open Payments
NPI 1669073052 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 64 payments from 16 companies in 2025. Trend: 2023 $168 · 2024 $1,193 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $319 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| PFIZER INC. | 6 | $126 |
| Novo Nordisk Inc | 5 | $97 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $85 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $48 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: REPATHA, VYNDAQEL, Wegovy, ONPATTRO, JARDIANCE, Kerendia, WAINUA, FARXIGA.
Industry payments across OH — which companies pay providers there.
